India to Sri Lanka: Digoxin Export Trade Route

The India to Sri Lanka Digoxin corridor is one of India's established pharmaceutical export routes, with 16 shipments documented worth a combined $124.7K USD. The route is dominated by VENOR PHARMA LIMITED, which alone accounts for roughly 28% of all export value, reflecting the consolidated nature of India's digoxin manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $7.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with digoxin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 30.9%, placing it at rank #4 among India's top digoxin export destinations globally.

On the import side, key buyers of Indian digoxin in Sri Lanka include TO THE ORDER OF, BANK OF CEYLON, M S MEDICAL SUPPLIES DIVISION MSD MINISTRY OF and 11 others. TO THE ORDER OF is the single largest importer with 1 shipments valued at $35.1K USD.

India's digoxin exports to Sri Lanka are driven primarily by a handful of large-scale manufacturers. VENOR PHARMA LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Sri Lanka benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VENOR PHARMA LIMITED, SAMARTH LIFE SCIENCES PRIVATE LIMITED, VERVE HUMAN CARE LABORATORIES — together account for 74% of total trade value on this route. The average shipment value of $7.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as digoxin injection bp 0.5mg/2ml dixin 2 and pharmaceuticals:digoxin inj. 250mcg/ml,2ml digiver.b.no.e1582303 md.jun.2023 ed.may.2025, suggesting that buyers in Sri Lanka tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF is the largest importer with 1 shipments worth $35.1K USD — representing 28% of all digoxin imports from India on this route. A total of 14 buyers are active on this corridor.